TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive DCE Board Approves Concept For New $850,000 Year Grant Program To Study Viruses In Cervical Cancer November 9, 1984
TCL Archive DCCR Merit Review Finds some Excellent contract Projects, Some Not So Good; Some Are Terminated February 25, 1977
TCL Archive News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions April 27, 2012
